08 Oct 2025 Confo Therapeutics awarded VLAIO grant for development of ultra-long-acting antibody-based GPCR therapeutics in endocrine and metabolic conditions Multiple categories
06 Oct 2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Multiple categories
03 Oct 2025 New approach can drastically reduce antibiotic prescription for children Multiple categories
24 Sep 2025 Enhertu plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer Multiple categories
16 Sep 2025 Aphea.Bio wins VLAIO grant to evolve from pioneer to powerhouse in biological solutions for farmers Multiple categories
15 Sep 2025 Mdxhealth announces closing of Exosome Diagnostics acquisition from Bio-Techne Multiple categories
10 Sep 2025 GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions Multiple categories
09 Sep 2025 Capricorn Healthtech Fund II kicks off with first investment in Aspect Analytics’ € 10 million Series A round Multiple categories
03 Sep 2025 Allegro appoints life sciences veteran as Chief Operating Officer to advance osteoarthritis treatment Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
